Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 4 (9) , e384
Abstract
Background Over 100 000 patients await renal transplantation and 4000 die per year. Compounding this mismatch between supply and demand is delayed graft function which contributes to short-term and long-term graft failures. Previously, we reported that thrombin-targeted perfluorocarbon nanoparticles (PFC-NP) protect kidneys from ischemic renal injury after transient arterial occlusion. Here we hypothesize that perfusion of renal allografts with PFC-NP similarly can protect graft function after an ischemic interval. Methods After 60 minutes of warm ischemia, male Lewis rats underwent left renal explantation followed by renal perfusion with 5 mL of standard perfusate alone (N = 3) or with 0.3 mL of untargeted PFC-NP (N = 5) or 0.3 mL thrombin-targeted of PFC NP functionalized with phenylalanine-proline-arginine-chloromethylketone (PPACK) (PFC-PPACK), an irreversible thrombin inhibitor (N = 5). Kidneys underwent 6 hours of cold storage, followed by transplantation into recipients and native nephrectomy. Animals were euthanized at 24 hours for tissue collection or at 48 hours for blood and renal tissue collection. A survival experiment was performed using the same protocol with saline control (N = 3), PFC-NP (N = 3) or PFC-PPACK (N = 6). Results Serum creatinine was improved for the PFC-PPACK groups as compared with control groups (P < 0.04). Kaplan-Meier survival curves also indicated increased longevity (P < 0.05). Blinded histologic scoring revealed markedly attenuated renal damage in the PFC-PPACK group compared to untreated animals (2.75 1.60 versus 0.83 +/- 3.89; P = 0.0001) and greater preservation of renal vasculature. Conclusions These results validate an NP-based approach to improve renal graft function as antithrombin NPs improved allograft function, decreased renal damage, protected vasculature, and improved longevity.Keywords
This publication has 14 references indexed in Scilit:
- Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Molecular Imaging of Atherosclerosis with Nanoparticle-Based Fluorinated MRI Contrast AgentsNanomedicine, 2015
- Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injuryAmerican Journal of Physiology-Renal Physiology, 2015
- CD47 Blockade Reduces Ischemia-Reperfusion Injury and Improves Outcomes in a Rat Kidney Transplant ModelTransplantation, 2014
- Renal hazards of anticoagulant therapyNature Reviews Nephrology, 2013
- Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosisJournal of Thrombosis and Haemostasis, 2011
- Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular AtrophyTransplantation, 2010
- Renal Hypoxia and Dysoxia After Reperfusion of the Ischemic KidneyMolecular Medicine, 2008
- Major effects of delayed graft function and cold ischaemia time on renal allograft survivalNephrology Dialysis Transplantation, 2006
- Endothelial injury and dysfunction: Role in the extension phase of acute renal failureKidney International, 2004